Treatment of Myasthenia Gravis With High-Dose Cholinesterase Inhibitors and Calcineurin Inhibitors Caused Spontaneous Muscle Cramps in Patients. Issue 5 (September 2018)
- Record Type:
- Journal Article
- Title:
- Treatment of Myasthenia Gravis With High-Dose Cholinesterase Inhibitors and Calcineurin Inhibitors Caused Spontaneous Muscle Cramps in Patients. Issue 5 (September 2018)
- Main Title:
- Treatment of Myasthenia Gravis With High-Dose Cholinesterase Inhibitors and Calcineurin Inhibitors Caused Spontaneous Muscle Cramps in Patients
- Authors:
- Masuda, Masayuki
Utsumi, Hiroya
Tanaka, Sachiko
Maeno, Akemi
Yamamoto, Mamiko
Sugiyama, Kentaro
Hirano, Toshihiko
Aizawa, Hitoshi - Abstract:
- Abstract : Objectives: The objective of this study was to investigate the influence of treatment with cholinesterase inhibitors (ChEIs) and calcineurin inhibitors (CNIs) on the occurrence of cramps in myasthenia gravis (MG) patients. Methods: The frequency and duration of cramp and serum electrolytes were evaluated in 81 patients with MG. The patients were classified using Myasthenia Gravis Foundation of America postintervention status scores based on the treatment and the responsiveness to the treatment. Quantitative MG score, MG activities of daily living score, MG composite score, or MG quality of life 15 score was used to assess the health-related quality of life (QOL). Results: Muscle cramps developed in 44 (54.3%) of 81 MG patients. The scores of MG activities of daily living, MG composite, or MG-QOL 15-item questionnaire in patients with cramp were significantly higher than those in patients without cramps ( P = 0.002, P = 0.01, or P = 0.0022, respectively). The serum magnesium concentrations were lower in patients treated with CNI (n = 16) than in those not treated with CNI (n = 65) ( P = 0.002). The probability of cramps was significantly higher in patients treated with ChEIs (≥180 mg/d) in addition to CNI than in patients who were treated with a low dose of ChEIs (⩽60 mg/d) without concomitant CNI treatment ( P = 0.017). Conclusions: Our data suggested that treatment with a high dose of ChEI and CNI accelerated the probability of cramps and reduced the QOL in MGAbstract : Objectives: The objective of this study was to investigate the influence of treatment with cholinesterase inhibitors (ChEIs) and calcineurin inhibitors (CNIs) on the occurrence of cramps in myasthenia gravis (MG) patients. Methods: The frequency and duration of cramp and serum electrolytes were evaluated in 81 patients with MG. The patients were classified using Myasthenia Gravis Foundation of America postintervention status scores based on the treatment and the responsiveness to the treatment. Quantitative MG score, MG activities of daily living score, MG composite score, or MG quality of life 15 score was used to assess the health-related quality of life (QOL). Results: Muscle cramps developed in 44 (54.3%) of 81 MG patients. The scores of MG activities of daily living, MG composite, or MG-QOL 15-item questionnaire in patients with cramp were significantly higher than those in patients without cramps ( P = 0.002, P = 0.01, or P = 0.0022, respectively). The serum magnesium concentrations were lower in patients treated with CNI (n = 16) than in those not treated with CNI (n = 65) ( P = 0.002). The probability of cramps was significantly higher in patients treated with ChEIs (≥180 mg/d) in addition to CNI than in patients who were treated with a low dose of ChEIs (⩽60 mg/d) without concomitant CNI treatment ( P = 0.017). Conclusions: Our data suggested that treatment with a high dose of ChEI and CNI accelerated the probability of cramps and reduced the QOL in MG patients. … (more)
- Is Part Of:
- Clinical neuropharmacology. Volume 41:Issue 5(2018)
- Journal:
- Clinical neuropharmacology
- Issue:
- Volume 41:Issue 5(2018)
- Issue Display:
- Volume 41, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 41
- Issue:
- 5
- Issue Sort Value:
- 2018-0041-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-09
- Subjects:
- cholinesterase inhibitor -- calcineurin inhibitor -- serum electrolytes -- muscle cramp -- myasthenia gravis
Neuropharmacology -- Periodicals
615.78 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00002826-000000000-00000 ↗
http://journals.lww.com/clinicalneuropharm/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/WNF.0000000000000295 ↗
- Languages:
- English
- ISSNs:
- 0362-5664
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.310600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10740.xml